MDV3100

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 29/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Healthy Subjects

Conditions

Healthy Subjects, Pharmacokinetics of MDV3100

Trial Timeline

Apr 1, 2011 → Jul 1, 2011

NCT ID

NCT01911715

About MDV3100

MDV3100 is a phase 1 stage product being developed by Astellas Pharma for Healthy Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT01911715. Target conditions include Healthy Subjects, Pharmacokinetics of MDV3100.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Subjects were approved

Approved (20) Terminated (1) Active (0)

✅mRNA-1273.712ModernaApproved

✅Cholestyramine + Colesevelam HClDaiichi SankyoApproved

✅Cholestyramine + Cholestyramine + TangDaiichi SankyoApproved

✅Olmesartan medoxomil + Irbesartan + ValsartanDaiichi SankyoApproved

✅Perampanel 6 MGEisaiApproved

✅eszopiclone, zolpidem, placeboSumitomo PharmaApproved

✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (7)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01606982	Pre-clinical	Completed	—	—	Metastatic Castration-Resistant Prostate Cancer
NCT01911741	Phase 1	Completed	Nov 1, 2012	Mar 1, 2013	Healthy Subjects
NCT01565928	Phase 1	Completed	Jan 24, 2012	Feb 26, 2018	Prostate Cancer
NCT01901133	Phase 1	Completed	Oct 1, 2011	Jan 1, 2012	Pharmacokinetics of MDV3100
NCT01911715	Phase 1	Completed	Apr 1, 2011	Jul 1, 2011	Healthy Subjects
NCT01284920	Phase 1/2	Completed	Nov 2, 2010	Jul 2, 2014	Prostate Cancer
NCT00510718	Phase 1	Completed	Jul 23, 2007	Apr 2, 2018	Prostate Cancer

Competing Products

20 competing products in Healthy Subjects

See all competitors

Product	Company	Stage	Hype Score
Use of Wearable Digital Sensors After mRNA Vaccination in Adults	Moderna	Preclinical	0
mRNA-0184	Moderna	Phase 1	0
mRNA-6231	Moderna	Phase 1	0
Letrozole	Dr. Reddy's Laboratories	Phase 1	26
Isotretinoin	Dr. Reddy's Laboratories	Phase 1	26
Fexofenadine	Dr. Reddy's Laboratories	Phase 1	26
Sertraline	Dr. Reddy's Laboratories	Phase 1	26
Nizatidine + Axid	Dr. Reddy's Laboratories	Phase 1	26
Anastrozole	Dr. Reddy's Laboratories	Phase 1	26
mRNA-1273.712	Moderna	Approved	0
Risperidone	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
Metformin + Glucophage	Dr. Reddy's Laboratories	Phase 1	26
Lamotrigine	Dr. Reddy's Laboratories	Phase 1	26
mRNA-0184	Moderna	Phase 1	0
Divalproex Sodium	Dr. Reddy's Laboratories	Phase 1	26
Sirolimus	Dr. Reddy's Laboratories	Phase 1	26
Glimepiride	Dr. Reddy's Laboratories	Phase 1	26
Ziprasidone Hydrochloride	Dr. Reddy's Laboratories	Phase 1	26
Naproxen sodium	Dr. Reddy's Laboratories	Phase 1	26